Cresco Labs (CRLBF) EBIT Margin (2020 - 2026)
Cresco Labs (CRLBF) reported EBIT Margin of 7.38% for Q1 2026, down 81.0% on a YoY basis from 38.86% in Q1 2025, and up 115.79% quarter-over-quarter from 46.76% in Q4 2025.
Cresco Labs (CRLBF) EBIT Margin (2020 - 2026) Analysis & Trends
Cresco Labs has reported EBIT Margin for 7 years, with the latest figure at 7.38% in Q1 2026.
- For the quarter ending Q1 2026, EBIT Margin fell 81.0% year-over-year to 7.38%; the trailing twelve-month figure through Mar 2026 stood at 4.74% (down 1773.0% YoY), and the FY2025 full-year result was 4.27%, down 1908.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 7.38%, up from 46.76% in the prior quarter.
- The five-year high for EBIT Margin was 17.56% in Q2 2024, with the low at 71.89% in Q4 2022.
- Historically, EBIT Margin has averaged 2.44% across 5 years, with a median of 9.45% in 2022.
- The largest YoY upside for EBIT Margin was 13024 bps in 2022 against a maximum downside of 7903 bps in 2022.
- Cresco Labs' EBIT Margin stood at 71.89% in 2022, then jumped by 120 bps to 14.4% in 2023, then fell by 23 bps to 11.03% in 2024, then plunged by 524 bps to 46.76% in 2025, then jumped by 116 bps to 7.38% in 2026.
- The last three EBIT Margin figures came in at 7.38% (Q1 2026), 46.76% (Q4 2025), and 10.81% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -122.23% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 21.55% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -12.88% |
| 10 | Cresco Labs | - | - | 75.45 Mn | 7.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.38% |
| Dec 31, 2025 | -46.76% |
| Sep 30, 2025 | 10.81% |
| Jun 30, 2025 | 9.86% |
| Mar 31, 2025 | 8.20% |
| Dec 31, 2024 | 11.03% |
| Sep 30, 2024 | 14.65% |
| Jun 30, 2024 | 17.56% |
| Mar 31, 2024 | 15.82% |
| Dec 31, 2023 | 14.40% |
| Sep 30, 2023 | -56.55% |
| Jun 30, 2023 | -5.43% |
| Mar 31, 2023 | 1.85% |
| Dec 31, 2022 | -71.89% |
| Sep 30, 2022 | 7.72% |
| Jun 30, 2022 | 10.39% |
| Mar 31, 2022 | 9.45% |
| Dec 31, 2021 | 7.14% |
| Sep 30, 2021 | -122.52% |
| Jun 30, 2021 | 7.08% |